Skip to content
SCLC Transformation in EGFR NSCLC episode artwork

May 2, 2023 37 min

SCLC Transformation in EGFR NSCLC

from Lung Cancer Considered Hosted by IASLC

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on EGFR NSCLC and transformation to small cell lung cancer, a relatively new finding since the introduction of targeted therapy. Guests are: Dr. Shigeki Umemura Dr. Shigeki Umemura is from the Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan. His interests include targeted therapy in lung cancer, including genomic profiling of small cell lung cancer, evaluation of tumor microenvironment and its association with response to therapy and resistance mechanisms for disease progression. Dr. Zofia Piotrowska Dr. Zofia Piotrowska is an assistant professor of medicine at HMS and clinical researcher and lung cancer medical oncologist at the Massachusetts General Hospital. Dr. Piotrowska has an interest in understanding and overcoming resistance to targeted therapies in lung cancer, particularly among patients with EGFR-mutant NSCLC.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

SCLC Transformation in EGFR NSCLC

0:00 37:14

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 37 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on May 2, 2023.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.